Literature DB >> 27764668

Publicly Available Data Provide Evidence against NR1H3 R415Q Causing Multiple Sclerosis.

Eric Vallabh Minikel1, Daniel G MacArthur2.   

Abstract

It has recently been reported that an NR1H3 missense variant, R415Q, causes a novel familial form of multiple sclerosis (Wang et al., 2016a). This claim is at odds with publicly available data from the Exome Aggregation Consortium (ExAC; http://exac.broadinstitute.org). The allele frequency of R415Q is not significantly higher in cases (0.024%-0.049%) than in ExAC population controls (0.031%), whereas if R415Q conferred even 50% lifetime risk of developing MS, it would be hundreds of times more common in cases than in controls. The upper bound of the 95% confidence interval of penetrance for R415Q can be estimated at 2.2% for women and 1.2% for men, indicating that even if this variant is disease associated, individuals harboring the variant would have a lifetime risk of developing MS no higher than a few percent. ExAC data should be considered when evaluating claims of variant pathogenicity. This Matters Arising paper is in response to Wang et al. (2016a), published in Neuron. See also the related Matters Arising paper by The International Multiple Sclerosis Genetics Consortium (2016) and the response by Wang et al. (2016b), published in this issue.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27764668      PMCID: PMC5123684          DOI: 10.1016/j.neuron.2016.09.054

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  20 in total

1.  A novel neurodevelopmental disorder associated with compound heterozygous variants in the huntingtin gene.

Authors:  Lance H Rodan; Julie Cohen; Ali Fatemi; Tammy Gillis; Diane Lucente; James Gusella; Jonathan D Picker
Journal:  Eur J Hum Genet       Date:  2016-06-22       Impact factor: 4.246

2.  Concurrence of multiple sclerosis and inflammatory bowel disease.

Authors:  A D Sadovnick; D W Paty; G Yannakoulias
Journal:  N Engl J Med       Date:  1989-09-14       Impact factor: 91.245

3.  Pervasive sharing of genetic effects in autoimmune disease.

Authors:  Chris Cotsapas; Benjamin F Voight; Elizabeth Rossin; Kasper Lage; Benjamin M Neale; Chris Wallace; Gonçalo R Abecasis; Jeffrey C Barrett; Timothy Behrens; Judy Cho; Philip L De Jager; James T Elder; Robert R Graham; Peter Gregersen; Lars Klareskog; Katherine A Siminovitch; David A van Heel; Cisca Wijmenga; Jane Worthington; John A Todd; David A Hafler; Stephen S Rich; Mark J Daly
Journal:  PLoS Genet       Date:  2011-08-10       Impact factor: 5.917

4.  Genetic variants in IL2RA and IL7R affect multiple sclerosis disease risk and progression.

Authors:  Anthony L Traboulsee; Cecily Q Bernales; Jay P Ross; Joshua D Lee; A Dessa Sadovnick; Carles Vilariño-Güell
Journal:  Neurogenetics       Date:  2014-04-26       Impact factor: 2.660

5.  Autoimmune disease in families with multiple sclerosis: a population-based study.

Authors:  Sreeram Varadharajan Ramagopalan; David Alexandre Dyment; William Valdar; Blanca Marcela Herrera; Maria Criscuoli; Irene Mei Ling Yee; Adele Dessa Sadovnick; George Cornell Ebers
Journal:  Lancet Neurol       Date:  2007-07       Impact factor: 44.182

6.  The penetrance of copy number variations for schizophrenia and developmental delay.

Authors:  George Kirov; Elliott Rees; James T R Walters; Valentina Escott-Price; Lyudmila Georgieva; Alexander L Richards; Kimberly D Chambert; Gerwyn Davies; Sophie E Legge; Jennifer L Moran; Steven A McCarroll; Michael C O'Donovan; Michael J Owen
Journal:  Biol Psychiatry       Date:  2013-08-28       Impact factor: 13.382

7.  Guidelines for investigating causality of sequence variants in human disease.

Authors:  D G MacArthur; T A Manolio; D P Dimmock; H L Rehm; J Shendure; G R Abecasis; D R Adams; R B Altman; S E Antonarakis; E A Ashley; J C Barrett; L G Biesecker; D F Conrad; G M Cooper; N J Cox; M J Daly; M B Gerstein; D B Goldstein; J N Hirschhorn; S M Leal; L A Pennacchio; J A Stamatoyannopoulos; S R Sunyaev; D Valle; B F Voight; W Winckler; C Gunter
Journal:  Nature       Date:  2014-04-24       Impact factor: 49.962

8.  De Novo Mutations in PDE10A Cause Childhood-Onset Chorea with Bilateral Striatal Lesions.

Authors:  Niccolò E Mencacci; Erik-Jan Kamsteeg; Kosuke Nakashima; Lea R'Bibo; David S Lynch; Bettina Balint; Michèl A A P Willemsen; Matthew E Adams; Sarah Wiethoff; Kazunori Suzuki; Ceri H Davies; Joanne Ng; Esther Meyer; Liana Veneziano; Paola Giunti; Deborah Hughes; F Lucy Raymond; Miryam Carecchio; Giovanna Zorzi; Nardo Nardocci; Chiara Barzaghi; Barbara Garavaglia; Vincenzo Salpietro; John Hardy; Alan M Pittman; Henry Houlden; Manju A Kurian; Haruhide Kimura; Lisenka E L M Vissers; Nicholas W Wood; Kailash P Bhatia
Journal:  Am J Hum Genet       Date:  2016-04-07       Impact factor: 11.025

9.  Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples.

Authors:  Roddy Walsh; Kate L Thomson; James S Ware; Birgit H Funke; Jessica Woodley; Karen J McGuire; Francesco Mazzarotto; Edward Blair; Anneke Seller; Jenny C Taylor; Eric V Minikel; Daniel G MacArthur; Martin Farrall; Stuart A Cook; Hugh Watkins
Journal:  Genet Med       Date:  2016-08-17       Impact factor: 8.822

10.  Rare loss-of-function variants in SETD1A are associated with schizophrenia and developmental disorders.

Authors:  Tarjinder Singh; Mitja I Kurki; David Curtis; Shaun M Purcell; Lucy Crooks; Jeremy McRae; Jaana Suvisaari; Himanshu Chheda; Douglas Blackwood; Gerome Breen; Olli Pietiläinen; Sebastian S Gerety; Muhammad Ayub; Moira Blyth; Trevor Cole; David Collier; Eve L Coomber; Nick Craddock; Mark J Daly; John Danesh; Marta DiForti; Alison Foster; Nelson B Freimer; Daniel Geschwind; Mandy Johnstone; Shelagh Joss; Georg Kirov; Jarmo Körkkö; Outi Kuismin; Peter Holmans; Christina M Hultman; Conrad Iyegbe; Jouko Lönnqvist; Minna Männikkö; Steve A McCarroll; Peter McGuffin; Andrew M McIntosh; Andrew McQuillin; Jukka S Moilanen; Carmel Moore; Robin M Murray; Ruth Newbury-Ecob; Willem Ouwehand; Tiina Paunio; Elena Prigmore; Elliott Rees; David Roberts; Jennifer Sambrook; Pamela Sklar; David St Clair; Juha Veijola; James T R Walters; Hywel Williams; Patrick F Sullivan; Matthew E Hurles; Michael C O'Donovan; Aarno Palotie; Michael J Owen; Jeffrey C Barrett
Journal:  Nat Neurosci       Date:  2016-03-14       Impact factor: 24.884

View more
  10 in total

Review 1.  Settling the score: variant prioritization and Mendelian disease.

Authors:  Karen Eilbeck; Aaron Quinlan; Mark Yandell
Journal:  Nat Rev Genet       Date:  2017-08-14       Impact factor: 53.242

Review 2.  Genetics of Multiple Sclerosis: An Overview and New Directions.

Authors:  Nikolaos A Patsopoulos
Journal:  Cold Spring Harb Perspect Med       Date:  2018-07-02       Impact factor: 6.915

3.  NR1H3 p.Arg415Gln Is Not Associated to Multiple Sclerosis Risk.

Authors: 
Journal:  Neuron       Date:  2016-10-19       Impact factor: 17.173

4.  Linkage analysis and whole exome sequencing identify a novel candidate gene in a Dutch multiple sclerosis family.

Authors:  Julia Y Mescheriakova; Annemieke Jmh Verkerk; Najaf Amin; André G Uitterlinden; Cornelia M van Duijn; Rogier Q Hintzen
Journal:  Mult Scler       Date:  2018-06-06       Impact factor: 6.312

5.  Complement C7 is a novel risk gene for Alzheimer's disease in Han Chinese.

Authors:  Deng-Feng Zhang; Yu Fan; Min Xu; Guihong Wang; Dong Wang; Jin Li; Li-Li Kong; Hejiang Zhou; Rongcan Luo; Rui Bi; Yong Wu; Guo-Dong Li; Ming Li; Xiong-Jian Luo; Hong-Yan Jiang; Liwen Tan; Chunjiu Zhong; Yiru Fang; Chen Zhang; Nengyin Sheng; Tianzi Jiang; Yong-Gang Yao
Journal:  Natl Sci Rev       Date:  2018-11-05       Impact factor: 17.275

Review 6.  Regulation of Brain Cholesterol: What Role Do Liver X Receptors Play in Neurodegenerative Diseases?

Authors:  Kevin Mouzat; Aleksandra Chudinova; Anne Polge; Jovana Kantar; William Camu; Cédric Raoul; Serge Lumbroso
Journal:  Int J Mol Sci       Date:  2019-08-08       Impact factor: 5.923

7.  Expanding ACMG variant classification guidelines into a general framework.

Authors:  Emmanuelle Masson; Wen-Bin Zou; Emmanuelle Génin; David N Cooper; Gerald Le Gac; Yann Fichou; Na Pu; Vinciane Rebours; Claude Férec; Zhuan Liao; Jian-Min Chen
Journal:  Hum Genomics       Date:  2022-08-16       Impact factor: 6.481

8.  Whole Exome Sequencing in Multi-Incident Families Identifies Novel Candidate Genes for Multiple Sclerosis.

Authors:  Julia Horjus; Tineke van Mourik-Banda; Marco A P Heerings; Marina Hakobjan; Ward De Witte; Dorothea J Heersema; Anne J Jansen; Eva M M Strijbis; Brigit A de Jong; Astrid E J Slettenaar; Esther M P E Zeinstra; Erwin L J Hoogervorst; Barbara Franke; Wiebe Kruijer; Peter J Jongen; Leo J Visser; Geert Poelmans
Journal:  Int J Mol Sci       Date:  2022-09-28       Impact factor: 6.208

9.  Highly Efficient, Rapid and Co-CRISPR-Independent Genome Editing in Caenorhabditis elegans.

Authors:  Harriet Prior; Ali K Jawad; Lauren MacConnachie; Asim A Beg
Journal:  G3 (Bethesda)       Date:  2017-11-06       Impact factor: 3.154

10.  Using high-resolution variant frequencies to empower clinical genome interpretation.

Authors:  Nicola Whiffin; Eric Minikel; Roddy Walsh; Anne H O'Donnell-Luria; Konrad Karczewski; Alexander Y Ing; Paul J R Barton; Birgit Funke; Stuart A Cook; Daniel MacArthur; James S Ware
Journal:  Genet Med       Date:  2017-05-18       Impact factor: 8.822

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.